These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23426590)

  • 1. Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery.
    Baena-Fustegueras JA; Pardina E; Balada E; Ferrer R; Catalán R; Rivero J; Casals I; Lecube A; Fort JM; Vargas V; Peinado-Onsurbe J
    JAMA Surg; 2013 Feb; 148(2):151-6. PubMed ID: 23426590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
    Schernthaner GH; Kopp HP; Krzyzanowska K; Kriwanek S; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 Jun; 36(6):395-401. PubMed ID: 16684123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
    Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-conventional markers of atherosclerosis before and after gastric banding surgery.
    Hanusch-Enserer U; Zorn G; Wojta J; Kopp CW; Prager R; Koenig W; Schillinger M; Roden M; Huber K
    Eur Heart J; 2009 Jun; 30(12):1516-24. PubMed ID: 19380349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life.
    Suter M; Calmes JM; Paroz A; Romy S; Giusti V
    Arch Surg; 2009 Apr; 144(4):312-8; discussion 318. PubMed ID: 19380643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halo effect for bariatric surgery: collateral weight loss in patients' family members.
    Woodard GA; Encarnacion B; Peraza J; Hernandez-Boussard T; Morton J
    Arch Surg; 2011 Oct; 146(10):1185-90. PubMed ID: 22006878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients.
    Pardina E; Ferrer R; Rivero J; Baena-Fustegueras JA; Lecube A; Fort JM; Vargas V; Catalán R; Peinado-Onsurbe J
    Obesity (Silver Spring); 2012 May; 20(5):1048-56. PubMed ID: 22193919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: A prospective, comparative analysis.
    Bowne WB; Julliard K; Castro AE; Shah P; Morgenthal CB; Ferzli GS
    Arch Surg; 2006 Jul; 141(7):683-9. PubMed ID: 16847241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
    Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
    Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential loss of fat and lean mass in the morbidly obese after bariatric surgery.
    Zalesin KC; Franklin BA; Lillystone MA; Shamoun T; Krause KR; Chengelis DL; Mucci SJ; Shaheen KW; McCullough PA
    Metab Syndr Relat Disord; 2010 Feb; 8(1):15-20. PubMed ID: 19929598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein intake compliance of morbidly obese patients undergoing bariatric surgery and its effect on weight loss and biochemical parameters.
    Raftopoulos I; Bernstein B; O'Hara K; Ruby JA; Chhatrala R; Carty J
    Surg Obes Relat Dis; 2011; 7(6):733-42. PubMed ID: 21925961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter?
    Bloomston M; Zervos EE; Camps MA; Goode SE; Rosemurgy AS
    Obes Surg; 1997 Oct; 7(5):414-9. PubMed ID: 9730495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese.
    Lin E; Gletsu N; Fugate K; McClusky D; Gu LH; Zhu JL; Ramshaw BJ; Papanicolaou DA; Ziegler TR; Smith CD
    Arch Surg; 2004 Jul; 139(7):780-4. PubMed ID: 15249413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients.
    Vilarrasa N; Vendrell J; Sánchez-Santos R; Broch M; Megia A; Masdevall C; Gomez N; Soler J; Pujol J; Bettónica C; Aranda H; Gómez JM
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):679-86. PubMed ID: 17608757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass.
    Moulin de Moraes CM; Mancini MC; de Melo ME; Figueiredo DA; Villares SM; Rascovski A; Zilberstein B; Halpern A
    Obes Surg; 2005 Oct; 15(9):1287-91. PubMed ID: 16259889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
    Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
    Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic Roux-en-Y gastric bypass: initial 2-year experience.
    Suter M; Giusti V; Héraief E; Zysset F; Calmes JM
    Surg Endosc; 2003 Apr; 17(4):603-9. PubMed ID: 12582767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass.
    Rossi M; Serpa Neto A; Rossi FM; Amarante RD; Alcântara GC; da Silva RB; Regina PF
    Surg Obes Relat Dis; 2009; 5(1):11-8. PubMed ID: 18996755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.